LONDON Cut-price copies of an expensive Roche biotech drug for blood cancer have taken 80 percent of the British market since launching last year, saving the healthcare system 80 million pounds ($113 million) a year, experts said on Wednesday.
(Reuters Health) - Mass-produced shoe inserts available on drugstore shelves and customized orthotics may not work for plantar heel pain, a research review suggests.
HAMBURG German authorities have confirmed outbreak of the highly pathogenic H5N6 bird flu type at a farm on an island off the German North Sea coast, the Schleswig-Holstein state agriculture ministry said on Wednesday.
Endo International Plc and two other companies have agreed to pay $270.8 million to resolve class action lawsuits alleging Endo paid a generic drug manufacturer to delay launching a cheaper version of its Lidoderm painkiller patch.
Reuters Health - Parents who endured “toxic stress” during childhood may be more likely to have kids with developmental delays and have a harder time coping with their children’s health issues, new research suggests.